Zouhair Bouaziz
University of Lyon
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Zouhair Bouaziz.
Journal of Medicinal Chemistry | 2015
Gustavo Jabor Gozzi; Zouhair Bouaziz; Evelyn Winter; Nathalia Daflon-Yunes; Dagmar Aichele; Abdelhamid Nacereddine; Christelle Marminon; Glaucio Valdameri; Waël Zeinyeh; Andre Bollacke; Jean Guillon; Aline Lacoudre; Noël Pinaud; Silvia Maria Suter Correia Cadena; Joachim Jose; Marc Le Borgne; Attilio Di Pietro
A series of indeno[1,2-b]indole-9,10-dione derivatives were synthesized as human casein kinase II (CK2) inhibitors. The most potent inhibitors contained a N(5)-isopropyl substituent on the C-ring. The same series of compounds was found to also inhibit the breast cancer resistance protein ABCG2 but with totally different structure-activity relationships: a N(5)-phenethyl substituent was critical, and additional hydrophobic substituents at position 7 or 8 of the D-ring or a methoxy at phenethyl position ortho or meta also contributed to inhibition. The best ABCG2 inhibitors, such as 4c, 4h, 4i, 4j, and 4k, behaved as very weak inhibitors of CK2, whereas the most potent CK2 inhibitors, such as 4a, 4p, and 4e, displayed limited interaction with ABCG2. It was therefore possible to convert, through suitable substitutions of the indeno[1,2-b]indole-9,10-dione scaffold, potent CK2 inhibitors into selective ABCG2 inhibitors and vice versa. In addition, some of the best ABCG2 inhibitors, which displayed a very low cytotoxicity, thus giving a high therapeutic ratio, and appeared not to be transported, constitute promising candidates for further investigations.
European Journal of Medicinal Chemistry | 2013
Pal Rongved; Gilbert Kirsch; Zouhair Bouaziz; Joachim Jose; Marc Le Borgne
Indenoindoles and their isomers cyclopentacarbazoles represent a wide class of synthetic and natural compounds. The great interest of these structures in (bio)organic chemistry is due to the use of various building blocks to get the elemental four ring structure. Depending on the synthetic route chosen, the chemists can achieve a large number of regioisomers. Each regioisomer can be considered as a template for specific functionalizations. Therefore, this mini-review aims (i) to present an overview on how to access this large family of heterocyclic compounds and (ii) to discuss their various biological applications and drug development in oncology (e.g. kinases), in CNS disorders (e.g. Alzheimers disease), in endocrinology (e.g. hormone replacement therapy) and oxidative stress (e.g. organ preservation). Past and present works will be presented through the systems 6-5-5-6 and 6-5-6-5 (combination of 6-membered and 5-membered rings).
Tetrahedron | 1995
Zouhair Bouaziz; Pascal Nebois; Houda Fillion; Jean-Louis Luche; Gérard Jenner
Abstract The additions of crotonaldehyde N,N-dimethylhydrazone to juglone and azanaphthoquinones are performed under sonochemical and thermal conditions. The rates and products of the reactions, Diels-Alder cycloaddition and amination of the quinones are largely modified by ultrasonic irradiation. In addition, the study reveals an apparent similarity between high pressure and ultrasonic effects.
Pharmaceuticals | 2015
Faten Alchab; Laurent Ettouati; Zouhair Bouaziz; Andre Bollacke; Jean-Guy Delcros; Christoph G. W. Gertzen; Holger Gohlke; Noël Pinaud; Mathieu Marchivie; Jean Guillon; Bernard Fenet; Joachim Jose; Marc Le Borgne
Due to their system of annulated 6-5-5-6-membered rings, indenoindoles have sparked great interest for the design of ATP-competitive inhibitors of human CK2. In the present study, we prepared twenty-one indeno[1,2-b]indole derivatives, all of which were tested in vitro on human CK2. The indenoindolones 5a and 5b inhibited human CK2 with an IC50 of 0.17 and 0.61 µM, respectively. The indeno[1,2-b]indoloquinone 7a also showed inhibitory activity on CK2 at a submicromolar range (IC50 = 0.43 µM). Additionally, a large number of indenoindole derivatives was evaluated for their cytotoxic activities against the cell lines 3T3, WI-38, HEK293T and MEF.
European Journal of Medicinal Chemistry | 2010
Samar Issa; Nadia Walchshofer; Issam Kassab; Hussein Termoss; Soulaima Chamat; Aziz Geahchan; Zouhair Bouaziz
The synthesis, structure elucidation and antitumoral activity of novel heterocyclic compounds containing a carbazole nucleus are reported. Oxazinocarbazoles were synthesized by application of the Mannich reaction to the corresponding hydroxylated derivatives leading to 41 new molecules. Their cytotoxic activity was evaluated against various human tumor cell lines including three leukemic cell lines: CEM and Jurkat (type T), Raji (type B); breast cancer cell line (MCF-7); colorectal cancer cell line (Caco-2). A primary screening at 100 microM allowed the selection of the 10 most active compounds, which showed an antiproliferative activity on all the cell lines. A dose-effect study between 12.5 and 100 microM sorted two compounds with a significant activity: 5t and 7e against leukemic cell lines CEM, Jurkat and Raji with IC50 values around 12 microM.
European Journal of Organic Chemistry | 2002
Zouhair Bouaziz; Arnaud Ghérardi; François Régnier; Marie-Elizabeth Sarciron; Xavier Bertheau; Bernard Fenet; Nadia Walchshofer; Houda Fillion
9-Ethyl-6-hydroxycarbazolequinone (9) was synthesized and submitted to a hetero Diels−Alder reaction towards azadienes 10a or 10b to afford the hydroxypyridocarbazole-5,11-diones 11 or 12a,b. A Bracher cyclization applied to compound 12b led to the 9-hydroxyquinoneimine 15 admixed with its 9-methyl ether 16. These compounds as well as other carbazolequinone derivatives were evaluated towards a purine nucleoside phosphorylase isolated from two strains of Toxoplasma gondii (a virulent strain RH and a cystic strain ME 49). The carbazolequinones 1a, 1b, 1d, 9 and pyridocarbazolequinones 2a, 4 and 5 have shown inhibitory activities similar or better than those observed with the reference compound 8-aminoguanosine. (© Wiley-VCH Verlag GmbH, 69451 Weinheim, Germany, 2002)
Drug Design Development and Therapy | 2015
Gustavo Jabor Gozzi; Zouhair Bouaziz; Evelyn Winter; Nathalia Daflon-Yunes; Mylène Honorat; Nathalie Guragossian; Christelle Marminon; Glaucio Valdameri; Andre Bollacke; Jean Guillon; Noël Pinaud; Mathieu Marchivie; Silvia Maria Suter Correia Cadena; Joachim Jose; Marc Le Borgne; Attilio Di Pietro
Ketonic indeno[1,2-b]indole-9,10-dione derivatives, initially designed as human casein kinase II (CK2) inhibitors, were recently shown to be converted into efficient inhibitors of drug efflux by the breast cancer resistance protein ABCG2 upon suited substitutions including a N5-phenethyl on C-ring and hydrophobic groups on D-ring. A series of ten phenolic and seven p-quinonic derivatives were synthesized and screened for inhibition of both CK2 and ABCG2 activities. The best phenolic inhibitors were about threefold more potent against ABCG2 than the corresponding ketonic derivatives, and showed low cytotoxicity. They were selective for ABCG2 over both P-glycoprotein and MRP1 (multidrug resistance protein 1), whereas the ketonic derivatives also interacted with MRP1, and they additionally displayed a lower interaction with CK2. Quite interestingly, they strongly stimulated ABCG2 ATPase activity, in contrast to ketonic derivatives, suggesting distinct binding sites. In contrast, the p-quinonic indenoindoles were cytotoxic and poor ABCG2 inhibitors, whereas a partial inhibition recovery could be reached upon hydrophobic substitutions on D-ring, similarly to the ketonic derivatives.
RSC Advances | 2015
Billel Belhani; Malika Berredjem; Marc Le Borgne; Zouhair Bouaziz; Jacques Lebreton; Nour-Eddine Aouf
An efficient and convenient one-pot synthesis of novel α-sulfamidophosphonates is described via a three-component reaction. This reaction was carried out through a three component condensation reaction of sulfonamide, an aromatic aldehyde and triethylphosphite under conventional/ultrasonic techniques, catalyst-free and solvent-free conditions. This methodology was established with many advantages, including mild reaction conditions, short reaction times, good yields, simple work-up procedures, and environmental friendliness.
Biochemical Pharmacology | 2002
Abdel Aouacheria; Benjamin Néel; Zouhair Bouaziz; Rigal Dominique; Nadia Walchshofer; Joëlle Paris; Houda Fillion; Germain Gillet
We previously reported that RSV-transformed quail neuroretina cells (QNR-ts68) were highly resistant to apoptosis provoked by serum withdrawal, and that this property was due to v-Src kinase activity. The present study investigates the cytotoxic effect and the functional mechanism of carbazolequinone-mediated cell death in this system. QNR-ts68 cells were subjected to carbazolequinone treatment and both growth inhibition and cell death induction were examined using formazan assays. Cell death mechanism (both apoptosis and necrosis) was confirmed through phosphatidyl serine exposure and propidium iodide incorporation. Furthermore, the effect of active carbazolequinone was inhibited by a pan caspase inhibitor. Cytofluorimetric and immunofluorescence data demonstrated the activation of caspase-3 and the involvement of mitochondria. Therefore, this study clearly indicates that carbazolequinones could induce cell death in transformed cells displaying high levels of antiapoptotic tyrosine kinase activity. Further investigations would be necessary to elucidate the mechanisms by which these carbazolequinones act as antitumor agents.
Journal of Enzyme Inhibition and Medicinal Chemistry | 2015
Zouhair Bouaziz; Samar Issa; Jacques Gentili; Andreas Gratz; Andre Bollacke; Matthias U. Kassack; Joachim Jose; Lars Herfindal; Gro Gausdal; Stein Ove Døskeland; Catherine Mullié; Pascal Sonnet; Camille Desgrouas; Nicolas Taudon; Glaucio Valdameri; Attilio Di Pietro; Milad Baitiche; Marc Le Borgne
Abstract Four series of carbazole derivatives, including N-substituted-hydroxycarbazoles, oxazinocarbazoles, isoxazolocarbazolequinones, and pyridocarbazolequinones, were studied using diverse biological test methods such as a CE-based assay for CK2 activity measurement, a cytotoxicity assay with IPC-81 cell line, determination of MIC of carbazole derivatives as antibacterial agents, a Plasmodium falciparum susceptibility assay, and an ABCG2-mediated mitoxantrone assay. Two oxazinocarbazoles Ib and Ig showed CK2 inhibition with IC50 = 8.7 and 14.0 µM, respectively. Further chemical syntheses were realized and the 7-isopropyl oxazinocarbazole derivative 2 displayed a stronger activity against CK2 (IC50 = 1.40 µM). Oxazinocarbazoles Ib, Ig, and 2 were then tested against IPC-81 leukemia cells and showed the ability to induce leukemia cell death with IC50 values between 57 and 62 μM. Further investigations were also reported on antibacterial and antiplasmodial activities. No significant inhibitory activity on ABCG2 efflux pump was detected.